Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

How to access Pharma in Focus articles
  • If you're a current subscriber, See below

  • If you're new to Pharma in Focus, Click here

  • If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Email Address
Open Forum
Undecideds loom large in MA disclosure survey
Medicines Australia's doctor opinion poll on disclosure of value transfers has been presented as a strong endorsement for the new Code of Conduct but if undecideds swing the wrong way, the result could be problematic.
Pipeline Monitor
New options for weight loss
Weight loss options for obese patients have been increased by approval of two new weight reduction brands from Takeda and Novo Nordisk.
Industry data: is it worth the price?
At least 14 companies offer wholesale data to the Australian pharma industry with some pharmacos investing seven figure sums annually on data purchases. We're asking what industry thinks about the value of these services.
Approvals Action
Sanofi registers new Hib vaccine
Sanofi has registered a new DTP and Hib vaccine while Apotex has been busy on the OTC front.
PBS Snapshot
Cancer generics to suffer in October
PBS price cuts due in October will attack one of the last remaining areas in which generic companies have been able to increase their income from the PBS over the last year.